Llista d'autoritzacions de vaccins contra la COVID-19: diferència entre les revisions

Contingut suprimit Contingut afegit
Línia 1.370:
|TD=silver
|TG=silver
|TH=dodgerblue
|TJ=silver
|TL=silver
Linha 1.383 ⟶ 1.384:
|VC=dodgerblue
|VE=silver
|VN=dodgerbluesilver
|VU=silver
|WS=silver
Linha 1.396 ⟶ 1.397:
{{leftlegend|silver|Destinatari apte per a [[COVAX]] (avaluació en curs)}}
 
;Plena (4+27=<section begin="Moderna_FN"/>312<section end="Moderna_FN"/>)
<div style="margin-top: 0.3em; column-width: 20em;">
# [[Regne Unit]]<ref>{{ref-cite web |títol title=Information for Healthcare Professionals on COVID-19 Vaccine Moderna | website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA) |data= 8date=1 generApril 2021 | url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna | access-date=6 8 generApril 2021}}</ref><ref>{{ref-cite web |títol title=ConditionsSummary of Authorisationthe Public Assessment Report for COVID-19 Vaccine Moderna | website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA) |data date=19 8 generFebruary 2021 | url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/conditionssummary-of-authorisationthe-public-assessment-report-for-covid-19-vaccine-moderna | access-date=6 9 generApril 2021}}</ref>
# [[Islàndia]]<ref name="Iceland">{{ref-web|url=https://www.covid.is/vaccine-agreements|títol=An overview of vaccine contracts for Iceland |website=Directorate of Health|access-date= 20 març 2021}}</ref>
# [[Liechtenstein]]<<ref name="COVID-19 Vaccine Moderna EPAR">{{ref-web|títol=COVID-19 Vaccine Moderna EPAR | website=European Medicines Agency |data= 25 gener 2021 | url=https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca | access-date= 31 març 2021}}</ref><ref name="EU Marketing authorisation">{{ref-web|títol=Marketing authorisation | website=European Medicines Agency | url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation | access-date= 23 març 2021}}</ref><ref name="EU CMA QandA">{{cite press release | title=Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU | website=European | url=https://ec.europa.eu/commission/presscorner/home/en | access-date= 1 abril 2021}}</ref>
# [[Noruega]]<ref>{{ref-web|títol=Status på koronavaksiner under godkjenning per 6. januar 2021|url=https://legemiddelverket.no/nyheter/status-pa-koronavaksiner-under-godkjenning-per-6-januar-2021|access-date=2021-01-07|website=Statens legemiddelverk|llengua=nb-NO}}</ref>
# [[Suïssa]]<ref>{{cite press release|title=Swissmedic grants authorisation for the COVID-19 vaccine from Moderna |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zulassung-covid-19-impfstoff-moderna.html |publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]] |date= 12 gener 2020 |access-date= 12 gener 2020}}</ref>
# [[Unió Europea]]<ref name="EU approval">{{Cite press release|title=European Commission authorises second safe and effective vaccine against COVID-19|url=https://ec.europa.eu/commission/presscorner/detail/en/ip_21_3|access-date= 6 gener 2021|website=European Commission}}</ref><ref>{{cite press release|date= 6 gener 2021|title=EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU|url=https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-moderna-authorisation-eu|access-date= 6 gener 2021|publisher=European Medicines Agency}}</ref>
</div>
 
;Emergència (15+27=<section begin="Moderna_EN"/>1042<section end="Moderna_EN"/>)
<div style="margin-top: 0.3em; column-width: 20em;">
# [[Andorra]]<ref name="Andorra vaccines">{{ref-notícia|títol=Informació en relació amb la vacunació contra la COVID-19|editorial=Govern d’Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date= 14 març 2021}}</ref>
Linha 1.411 ⟶ 1.409:
# [[Canada]]<ref name="hc-moderna12-23">{{ref-web|títol=Regulatory Decision Summary – Moderna COVID-19 Vaccine – Health Canada |url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00736 |editor=Health Canada, Government of Canada |access-date=23 desembre 2020 |data=23 desembre 2020}}</ref><ref name="hcapps">{{ref-web|data=9 desembre 2020|títol=Drug and vaccine authorizations for COVID-19: List of applications received|url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|consulta=9 desembre 2020|editor=Health Canada, Government of Canada}}</ref>
# [[Estats Units]]{{efn|L'autorització nord-americana també inclou les tres nacions sobiranes de l'[[Acord d'Associació Lliure (d'Oceania)|Acord d'Associació Lliure]]: [[República de Palau|Palau]], [[Illes Marshall]] i [[Estats Federats de Micronèsia|Micronèsia]].<ref>{{cite press release | title=Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines | publisher=[[United States Department of the Interior]] (DOI) | date=12 desembre 2020 | url=https://www.doi.gov/oia/press/interior-applauds-inclusion-insular-areas-through-operation-warp-speed-receive-covid-19 | access-date= 13 gener 2021}} {{PD-notice}}</ref><ref>{{ref-notícia|url=https://www.hawaiipublicradio.org/post/asia-minute-palau-administers-vaccines-keep-country-free-covid#stream/0|editorial=[[Hawaii Public Radio]]|títol=Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID|nom=Bill|cognom=Dorman|data= 6 gener 2021|access-date= 13 gener 2021|name-list-style=vanc}}</ref>}}<ref name="FDA PR 20201218">{{cite press release | title=FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine | website=U.S. [[Food and Drug Administration]] (FDA) | url=https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid | access-date=18 desembre 2020}}</ref><ref name="CDC ACIP Moderna COVID-19 Vaccine">{{ref-publicació|vauthors=Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K|display-authors=6|data= desembre 2020|títol=The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine – United States, December 2020|url=https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm695152e1-H.pdf|publicació=MMWR. Morbidity and Mortality Weekly Report|volum=69|exemplar=5152|pàgines=1653–56|doi=10.15585/mmwr.mm695152e1|pmid=33382675|s2cid=229945697}}</ref>
# [[Islàndia]]{{efn|name=viaEMA}}
# [[Israel]]<ref name="israelmoderna">{{ref-web|títol= Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel|url=https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use|editor=modernatx.com |access-date= 4 gener 2021|data= 4 gener 2021}}</ref>
# [[Liechtenstein]]{{efn|name=viaEMA}}
# [[Regne Unit]]<ref>{{ref-web|títol=Information for Healthcare Professionals on COVID-19 Vaccine Moderna | website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA) |data= 8 gener 2021 | url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna | access-date= 8 gener 2021}}</ref><ref>{{ref-web|títol=Conditions of Authorisation for COVID-19 Vaccine Moderna | website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA) |data= 8 gener 2021 | url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/conditions-of-authorisation-for-covid-19-vaccine-moderna | access-date= 9 gener 2021}}</ref>
# [[Mongòlia]]<ref name="news.mn">{{Cite web|date=2021-01-11|title=Mongolia approved three Covid-19 vaccines - News.MN|url=https://news.mn/en/795048/|access-date=2021-04-01|website=News.MN - The source of news}}</ref>
# [[Qatar]]<ref name="Aljazeera">{{cite web|title=Qatar approves emergency use of Moderna’s COVID-19 vaccine|url=https://www.aljazeera.com/news/2021/2/10/qatar-approves-emergency-use-for-modernas-covid-19-vaccine|access-date=31 March 2021}}</ref>
# [[Noruega]]{{efn|name=viaEMA}}
# [[Saint Vincent i les Grenadines]]<ref name="auto2">{{ref-web|data= 11 febrer 2021|títol=Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021|url=https://www.gov.vc/images/pdf_documents/SRO-Public_Health_Emergency_Authorisation_of_Covid-19_Vaccine.pdf|access-date= 12 febrer 2021|website=Government of Saint Vincent and the Grenadines}}</ref>
# [[Singapur]]<ref>{{ref-web|data= 3 febrer 2021|títol=Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-singapore/singapore-becomes-first-in-asia-to-approve-modernas-covid-19-vaccine-idUSKBN2A30ZM|access-date= 3 febrer 2021|website=[[Reuters]]}}</ref>
# [[Suïssa]]<ref>{{cite press release|title=Swissmedic grants authorisation for the COVID-19 vaccine from Moderna |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zulassung-covid-19-impfstoff-moderna.html |publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]] |date=2020-01-12 |accessdate=2020-01-12}}</ref>
# [[Tailàndia]]<ref>{{cite web |title=Thailand reduces quarantine, paperwork for vaccinated |url=https://apnews.com/article/thailand-asia-pacific-coronavirus-pandemic-coronavirus-vaccine-b6abe7ede141b33a3a19ab7bb219fa12 |website=AP NEWS |date=1 April 2021}}</ref>
# [[LiechtensteinUnió Europea]]]<<ref name="COVID-19 Vaccine Moderna EPAR">{{ref-webefn|títolname=COVID-19 Vaccine Moderna EPAR viaEMA|Via website=Europeanautorització Medicines[[Agència AgencyEuropea |data=del 25Medicament]] gener<ref 2021 | urlname=https://www.ema.europa.eu/en/medicines/human/"Comirnaty EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca" | access-date= 31 març 2021}}</ref><ref name="EU Marketing authorisation">{{ref-cite web |títol title=Marketing authorisation | website=European Medicines Agency | url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation | access-date= 23 marçMarch 2021}}</ref><ref name="EU CMA QandA">{{cite press release | title=Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU | website=European | url=https://ec.europa.eu/commission/presscorner/home/en | access-date= 1 abrilApril 2021}}</ref><ref name="Vaxzevria EPAR" /><ref name="COVID-19 Vaccine Janssen EPAR" /><ref name="COVID-19 Vaccine Moderna EPAR">{{cite web | title=COVID-19 Vaccine Moderna EPAR | website=[[European Medicines Agency]] (EMA) | url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-moderna | access-date=20 January 2021}}</ref>}}
# [[Vietnam]]<ref>{{ref-notícia|títol=Vietnam approves US, Russia Covid-19 vaccines for emergency use |url=https://e.vnexpress.net/news/news/vietnam-approves-us-russia-covid-19-vaccines-for-emergency-use-4240528.html |access-date= 26 febrer 2021 |editorial=VnExpress}}</ref>
</div><section end="Moderna"/>